
Deciduous Therapeutics
Developer of novel therapeutics designed for the treatment of age-related diseases. The company's novel molecules can activate a critical endogenous immune surveillance mechanism to selectively remove...
Valuation
$0
Share Price
N/A
Total Raised
$26.5M
Last Round
N/A